Mon, November 20, 2017
Fri, November 17, 2017
Thu, November 16, 2017

Tazeen Ahmad Maintained (ASND) at Strong Buy with Decreased Target to $43 on, Nov 17th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-43-on-nov-17th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Tazeen Ahmad of B of A Securities, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Decreased Target from $46 to $43 on, Nov 17th, 2017.

Tazeen has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tazeen


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $50 on, Friday, September 22nd, 2017